Tyagarajan Seshu 4
4 · Candel Therapeutics, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Tyagarajan Seshu
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-12+65,000→ 65,000 totalExercise: $8.55Exp: 2035-02-12→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.